Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016

BACKGROUND: The Centers for Disease Control and Prevention (CDC) currently recommends dual therapy with ceftriaxone and azithromycin for gonorrhea to ensure effective treatment and slow emergence of antimicrobial resistance. Since 2013, the prevalence of reduced azithromycin susceptibility increased...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Main Authors: Katz, Alan R., Komeya, Alan Y., Kirkcaldy, Robert D., Whelen, A. Christian, Soge, Olusegun O., Papp, John R., Kersh, Ellen N., Wasserman, Glenn M., O’Connor, Norman P., O’Brien, Pamela S., Sato, Douglas T., Maningas, Eloisa V., Kunimoto, Gail Y., Tomas, Juval E.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748320/
https://ncbi.nlm.nih.gov/pubmed/28549097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix485
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares